Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Filings indexed 991 across all filing types
Latest filing 2023-10-05 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 September 2023. It details movements in authorised/registered share capital, issued shares, convertibles, and other share-related information. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for the month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing related to share capital movements rather than a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-05 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-09-28 English
Notification Letter and Request Form to Non-registered Holders - Notice of Publication of 2023 Interim Report
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 26 September 2023 from Pharmaron Beijing Co., Ltd. informing non-registered shareholders about the publication of the company's 2023 Interim Report on its website and the HKEX website. It provides instructions on how to request printed copies of this and future corporate communications. The document does not contain the interim report itself or any substantive financial data, but rather serves as a notice of the report's availability. The document length is 7309 characters, which is relatively short and consistent with a notification letter rather than a full report. According to the 'MENU VS MEAL' rule, such a document is classified as a Report Publication Announcement (RPA) because it announces the publication of a report rather than being the report itself.
2023-09-25 English
Notification Letter and Request Form to H Shareholders - Notice of Publication of 2023 Interim Report
Report Publication Announcement Classification · 100% confidence The document is a notification letter from Pharmaron Beijing Co., Ltd. informing shareholders about the publication of the 2023 Interim Report on the company's website. It provides instructions on how shareholders can access the report online or request a printed version. The document does not contain the actual interim report or substantive financial data but serves as a notice of the report's availability. The document length is 7293 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA) rather than the Interim Report (IR) itself.
2023-09-25 English
2023 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2023 INTERIM REPORT' and contains detailed financial highlights, management discussion and analysis, and interim condensed consolidated financial statements for the six months ended June 30, 2023. It includes comprehensive financial data such as revenue, profit, cash flows, segment results, and employee information. The length of the document is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which provides a comprehensive financial report for a period shorter than a full fiscal year. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2023
2023-09-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-09-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.